{"id":11030,"date":"2018-07-25T09:56:50","date_gmt":"2018-07-25T13:56:50","guid":{"rendered":"https:\/\/medicarereport.org\/?p=11030"},"modified":"2018-07-25T09:56:50","modified_gmt":"2018-07-25T13:56:50","slug":"the-medicare-part-d-program-could-have-saved-3-billion-in-2016","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=11030","title":{"rendered":"The Medicare Part D program could have saved $3 billion in 2016"},"content":{"rendered":"<p>According to new data from Health and Human Services (HHS), using generic drugs instead of their brand-name equivalents could have saved the Medicare Part D program approximately $3 billion in 2016 alone. The data found a relatively small number of brand-name therapies is responsible for significant spending. <a href=\"https:\/\/healthpayerintelligence.com\/news\/generic-drugs-could-have-saved-3b-for-medicare-part-d-program\">Read article here\u2026<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-10021\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-300x200.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-768x512.jpg 768w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-1024x683.jpg 1024w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>According to new data from Health and Human Services (HHS), using generic drugs instead of their brand-name equivalents could have<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,15],"tags":[],"class_list":["post-11030","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11030"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11030\/revisions"}],"predecessor-version":[{"id":11031,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11030\/revisions\/11031"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11030"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11030"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}